18 December 2012
Only a fraction of medicines bought in Russia are made here, and Russian drug companies are few. Dragging the pharmaceutical industry into the 21st century will require investment from foreign companies - and from the government, experts say.
05 December 2012
Russia's rapidly growing over-the-counter market, posting a 12% increase to reach RUB 480 billion (USD 16.4 billion) at the manufacturers' level in 2011, holds much potential for pharmaceutical companies. Although a slight decrease in growth was observed against the previous year, according to new analysis Emerging Markets Rx-to-OTC Switch: Forecasts and Opportunities by global consulting and research firm Kline & Company, the Russian market remains highly robust compared to the U.S. market's 2.4% growth and comparable with the neighboring emerging market of China posting 15.0%.
30 November 2012
Investments from its government and the international community continue; meanwhile, unhealthy lifestyles contribute to greater need for medications.
27 November 2012
The country still has enormous potential and is one of the few growing markets in what is a predominantly barren global economy. There is good cause for foreign businesses in Russia to be optimistic, not least in pharmaceuticals.
15 November 2012
Sberbank might invest up to $800 million to build a medical center in Moscow as part of a $1.5 billion hub presented Wednesday to upgrade the country's health care sector.
14 November 2012
Biotechnopark, which is currently under construction in Koltsovo near Novosibirsk, will establish a research center for collective use of upscale laboratory equipment for bacterial and viral researches. The question of further development of the Biotechnopark infrastructure was considered at a meeting of the regional government.
02 November 2012
A Russian venture-capital fund and an American investor have agreed to invest $2 million in VitaPortal, an online medical startup aiming to improve Russians' access to information on doctors, medicine and healthy living.
01 November 2012
New regulation in both countries will cut down registration procedures that can take up to 3 years, opening up new avenues.
28 October 2012
The Russian government plans to actively attract the world's largest pharmaceutical manufacturers to the country, through the creation of conditions to carry out clinical trials of their drugs in the country and providing their access to Russian patients, according to local media reports.
26 October 2012
Amid the falling dynamics in the European Union and the USA, Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) is considering a big expansion into the Russian pharmaceutical market, along with other BRIC (Brazil, Russia, India and China) markets, in the coming years.
24 June 2019
24 June 2019
21 June 2019
21 June 2019